ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 237020 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 237020; 2) Community: the network communities that were significantly associated with the response to NSC 237020; 3) Molecule: the relationships between components within communities and NSC 237020; 4) MDR: the compounds that were significantly associated with the NSC 237020.

NSC Compound Enrichment Correlation
NSC 718781 Erlotinib hydrochloride 0.0217366743178497 -0.26241931
NSC 726089 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate 0.0217366743178497 0.31086702
NSC 726217 Combretastatin A4-analogue 0.0217366743178497 0.35012205
NSC 726578 Null 0.0217366743178497 0.35821923
NSC 730009 cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0217366743178497 0.44335816
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0217366743178497 0.3139174
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.0217366743178497 0.15121655
NSC 750050 Null 0.0217366743178497 0.09686372
NSC 755880 Mitomycin (USAN) 0.0217366743178497 0.59653175
NSC 176632 Stannane, trimethyl[(4-morpholinylthioxomethyl)thio]- 0.0219858755288753 0.4783532
Total:154  Current:81    [First] [Prev] [Next] [Last]